Home
About
Overview
Sharing Data
ORCID
Help
History (17)
Overcoming barriers to biosimilars in inflammatory arthritis.
New Business Structures Creating Organizational Opportunities and Challenges for Work Disability Prevention.
Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery.
A functionally characterized test set of human induced pluripotent stem cells.
Sensorineural hearing loss following imatinib (Gleevec) administration.
See All 17 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Sensorineural hearing loss following imatinib (Gleevec) administration.
Lin HW, Roberts DS, Kay J, Stankovic KM. Sensorineural hearing loss following imatinib (Gleevec) administration. Otolaryngol Head Neck Surg. 2012 Feb; 146(2):335-7.
View in:
PubMed
subject areas
Benzamides
Female
Hearing Loss, Sensorineural
Humans
Imatinib Mesylate
Middle Aged
Piperazines
Protein Kinase Inhibitors
Pyrimidines
authors with profiles
Jonathan Kay MD